128 related articles for article (PubMed ID: 30636283)
1. Constitutively solvent-tolerant Pseudomonas taiwanensis VLB120∆ C∆ ttgV supports particularly high-styrene epoxidation activities when grown under glucose excess conditions.
Volmer J; Lindmeyer M; Seipp J; Schmid A; Bühler B
Biotechnol Bioeng; 2019 May; 116(5):1089-1101. PubMed ID: 30636283
[TBL] [Abstract][Full Text] [Related]
2. Engineering of Pseudomonas taiwanensis VLB120 for constitutive solvent tolerance and increased specific styrene epoxidation activity.
Volmer J; Neumann C; Bühler B; Schmid A
Appl Environ Microbiol; 2014 Oct; 80(20):6539-48. PubMed ID: 25128338
[TBL] [Abstract][Full Text] [Related]
3. NADH availability limits asymmetric biocatalytic epoxidation in a growing recombinant Escherichia coli strain.
Bühler B; Park JB; Blank LM; Schmid A
Appl Environ Microbiol; 2008 Mar; 74(5):1436-46. PubMed ID: 18192422
[TBL] [Abstract][Full Text] [Related]
4. Production host selection for asymmetric styrene epoxidation: Escherichia coli vs. solvent-tolerant Pseudomonas.
Kuhn D; Bühler B; Schmid A
J Ind Microbiol Biotechnol; 2012 Aug; 39(8):1125-33. PubMed ID: 22526330
[TBL] [Abstract][Full Text] [Related]
5. The application of constitutively solvent-tolerant P. taiwanensis VLB120ΔCΔttgV for stereospecific epoxidation of toxic styrene alleviates carrier solvent use.
Volmer J; Schmid A; Bühler B
Biotechnol J; 2017 Jul; 12(7):. PubMed ID: 28345250
[TBL] [Abstract][Full Text] [Related]
6. Making variability less variable: matching expression system and host for oxygenase-based biotransformations.
Lindmeyer M; Meyer D; Kuhn D; Bühler B; Schmid A
J Ind Microbiol Biotechnol; 2015 Jun; 42(6):851-66. PubMed ID: 25877162
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of StyAB from Pseudomonas sp. strain VLB120 as a two-component flavin-diffusible monooxygenase.
Otto K; Hofstetter K; Röthlisberger M; Witholt B; Schmid A
J Bacteriol; 2004 Aug; 186(16):5292-302. PubMed ID: 15292130
[TBL] [Abstract][Full Text] [Related]
8. Carbon metabolism and product inhibition determine the epoxidation efficiency of solvent-tolerant Pseudomonas sp. strain VLB120DeltaC.
Park JB; Bühler B; Panke S; Witholt B; Schmid A
Biotechnol Bioeng; 2007 Dec; 98(6):1219-29. PubMed ID: 17514751
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of recombinant Escherichia coli as biocatalyst for stereospecific epoxidation.
Park JB; Bühler B; Habicher T; Hauer B; Panke S; Witholt B; Schmid A
Biotechnol Bioeng; 2006 Oct; 95(3):501-12. PubMed ID: 16767777
[TBL] [Abstract][Full Text] [Related]
10. Metabolic response of Pseudomonas putida during redox biocatalysis in the presence of a second octanol phase.
Blank LM; Ionidis G; Ebert BE; Bühler B; Schmid A
FEBS J; 2008 Oct; 275(20):5173-90. PubMed ID: 18803670
[TBL] [Abstract][Full Text] [Related]
11. Production of enantiopure styrene oxide by recombinant Escherichia coli synthesizing a two-component styrene monooxygenase.
Panke S; Wubbolts MG; Schmid A; Witholt B
Biotechnol Bioeng; 2000 Jul; 69(1):91-100. PubMed ID: 10820335
[TBL] [Abstract][Full Text] [Related]
12. D-Xylose assimilation via the Weimberg pathway by solvent-tolerant Pseudomonas taiwanensis VLB120.
Köhler KA; Blank LM; Frick O; Schmid A
Environ Microbiol; 2015 Jan; 17(1):156-70. PubMed ID: 24934825
[TBL] [Abstract][Full Text] [Related]
13. Pilot-scale production of (S)-styrene oxide from styrene by recombinant Escherichia coli synthesizing styrene monooxygenase.
Panke S; Held M; Wubbolts MG; Witholt B; Schmid A
Biotechnol Bioeng; 2002 Oct; 80(1):33-41. PubMed ID: 12209784
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and metabolic response of
Wordofa GG; Kristensen M
Biotechnol Biofuels; 2018; 11():199. PubMed ID: 30034525
[TBL] [Abstract][Full Text] [Related]
15. Streamlined
Wynands B; Otto M; Runge N; Preckel S; Polen T; Blank LM; Wierckx N
ACS Synth Biol; 2019 Sep; 8(9):2036-2050. PubMed ID: 31465206
[TBL] [Abstract][Full Text] [Related]
16. Systems Analysis of NADH Dehydrogenase Mutants Reveals Flexibility and Limits of Pseudomonas taiwanensis VLB120's Metabolism.
Nies SC; Dinger R; Chen Y; Wordofa GG; Kristensen M; Schneider K; Büchs J; Petzold CJ; Keasling JD; Blank LM; Ebert BE
Appl Environ Microbiol; 2020 May; 86(11):. PubMed ID: 32245760
[TBL] [Abstract][Full Text] [Related]
17. Maximizing Biocatalytic Cyclohexane Hydroxylation by Modulating Cytochrome P450 Monooxygenase Expression in
Schäfer L; Karande R; Bühler B
Front Bioeng Biotechnol; 2020; 8():140. PubMed ID: 32175317
[TBL] [Abstract][Full Text] [Related]
18. Variability in subpopulation formation propagates into biocatalytic variability of engineered Pseudomonas putida strains.
Lindmeyer M; Jahn M; Vorpahl C; Müller S; Schmid A; Bühler B
Front Microbiol; 2015; 6():1042. PubMed ID: 26483771
[TBL] [Abstract][Full Text] [Related]
19. Subtoxic product levels limit the epoxidation capacity of recombinant E. coli by increasing microbial energy demands.
Kuhn D; Fritzsch FS; Zhang X; Wendisch VF; Blank LM; Bühler B; Schmid A
J Biotechnol; 2013 Jan; 163(2):194-203. PubMed ID: 22922011
[TBL] [Abstract][Full Text] [Related]
20. Biocatalytic conversion of cycloalkanes to lactones using an in-vivo cascade in Pseudomonas taiwanensis VLB120.
Karande R; Salamanca D; Schmid A; Buehler K
Biotechnol Bioeng; 2018 Feb; 115(2):312-320. PubMed ID: 28986995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
